Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury

INTRODUCTION: The clinical course of coronavirus 2019 (COVID-19) is heterogeneous, ranging from mild to severe multiorgan failure and death. In this study, we analyzed cell-free DNA (cfDNA) as a biomarker of injury to define the sources of tissue injury that contribute to such different trajectories...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JCI Insight
Hauptverfasser: Andargie, Temesgen E., Tsuji, Naoko, Seifuddin, Fayaz, Jang, Moon Kyoo, Yuen, Peter S.T., Kong, Hyesik, Tunc, Ilker, Singh, Komudi, Charya, Ananth, Wilkins, Kenneth, Nathan, Steven, Cox, Andrea, Pirooznia, Mehdi, Star, Robert A., Agbor-Enoh, Sean
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Clinical Investigation 2021
Schlagworte:
Clinical Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119224/
https://ncbi.nlm.nih.gov/pubmed/33651717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.147610
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge